A Canadian company is working on fast-acting, oral-dissolving psilocybin film.
Cybin Corp, a mushroom life sciences company focused on advancing psychedelic products derived from fungi, has announced development of an oral-dissolving film for the delivery of pharmaceutical-grade psilocybin.
(Think: Breath strips laced with psilocybin.)
“Cybin’s intention is to bypass the digestive system, which will provide faster-acting relief for individuals with anxiety disorders who require more immediate symptom relief,” said Cybin’s CEO Paul Glavine.
The company expects to launch psilocybin-based products in jurisdictions where the substance is not prohibited. Simultaneously, Cybin is structuring and supporting clinical studies across North America and other regions, through strategic academic and institutional partnerships.